 |
|
|
|
|
|
Product Details:
Payment & Shipping Terms:
|
| Product Name: | LY3437943 | Other Name: | Reta |
|---|---|---|---|
| CAS NO.: | 2381089-83-2 | Package: | 10 Vials Per Kit |
| MOQ: | 1 Kit (10 Vials) | M.F.: | C221H342N46O68 |
| M.W.: | 4731.33 | Delivery: | 100% |
Pharmaceutical Peptide Reta LY3437943 The Triple Agonist Medication for Weight Loss and Liver Fat Reduction
Product desciption:
According to current consensus guidelines for type 2 diabetes management, bodyweight management is as important as attaining glycaemic targets. Reta, a single peptide with agonist activity at the glucose-dependent insulinotropic polypeptide (GIP), GLP-1, and glucagon receptors, showed clinically meaningful glucose-lowering and bodyweight-lowering efficacy in a phase 1 study. We aimed to examine the efficacy and safety of Reta in people with type 2 diabetes across a range of doses.
In people with type 2 diabetes, Reta showed clinically meaningful improvements in glycaemic control and robust reductions in bodyweight, with a safety profile consistent with GLP-1 receptor agonists and GIP and GLP-1 receptor agonists. These phase 2 data also informed dose selection for the phase 3 programme.
Related products:
| GH 10iu 191AA | GH Fragment 176-191 | Adipotide |
| Melanotan II | Tirzepatide | Epithalon |
| Growth hormone | KPV | Oxytocin 2 |
| IGF1-LR3 | PT-141 | |
| HCG 5000iu Livzlon brand | P21 peptide | GHK-CU |
| HCG 5000iu | BPC-157 | Fox04 dri |
| TB-500 | CJC-1295 | DSIP |
| Hexarelin | HMG 75iu | AOD9604 |
| Ipamorelin | Sermorelin | MGF |
| Selank | Semaglutide | Peg-mgf |
| Semax | Tesamorelin | EPO 3000iu |
| Thymalin | Thymosin alpha | Follistatin 344 |
| GHRP2 | GHRP6 | Kisspeptin-10 Peptide |
| Gondorelin | IGF-1 DES | Dermorphin |
| IGF-LR3 | Melanotan | ACE-031 |
| Mots-C | Myostatin | AICAR |
| Please contact us for more products | ||
Product Photos:
Certifications:
Company:
FAQ:
Contact Person: jason
Tel: +86 17792557883
